PQDx 0005-005-00 
WHO PQDx PR 
May/2016, version 3.0
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The latest update (28 January 2021) includes the following addition and revision:
    biosafety aspects for working with antigen-detecting rapid diagnostic test;
    handling new variants of SARS-CoV-2 in the laboratory;
    updated assay decontamination before disposal;
    personal protectiv...e equipment (PPE) for specimen collection;
    addressing chemical hazards and their safe disposal; and
    the fourth edition of the WHO Laboratory Biosafety Manual (LBM4) is now available and the terminology in this guidance was aligned with the LBM4.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Plataforma clínica mundial de la COVID-19. Formulario de notificación  de casos presuntos de síndrome inflamatorio multisistémico (SIM)  en niños y adolescentes que coincide cronológicamente con la COVID-19
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Orientaciones provisionales 16 de diciembre de 2020
En el presente documento se resumen las orientaciones actuales de la OMS para la vigilancia de salud pública en relación con la coronavirosis de 2019 (COVID-19) en el ser humano debida a la infección por el coronavirus del síndrome respiratori...o agudo severo de tipo 2 (SARS-CoV-2).
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Actualizadas en el documento titulado «Vigilancia de salud pública en relación con la COVID-19» publicado el 16 de diciembre de 2020
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Lista de preguntas y respuestas sobre la priorización de pruebas diagnósticas para la confirmación de la infección por el SARS-CoV-2 orientada a dirigir las necesidades de adquisición de los sistemas de salud.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Journal of Infectious Diseases and Therapeutics, 2013, 1, 17-24
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Epidemiologisches Bulletin3 | 202121. Januar 2021 (online vorab)
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                9 March 2022, Timely and accurate diagnostic testing for SARS-CoV-2 is an essential part of a comprehensive COVID-19 response strategy. Ag-RDTs can be performed by individuals in which they collect their own specimen, perform a simple rapid test and interpret their test result themselves at a time a...nd place of their choosing, termed COVID-19 self-testing. This interim guidance provides a new recommendation that COVID-19 self-testing, using SARS-CoV-2 Ag-RDTs, should be offered as part of SARS-CoV-2 testing services. It also includes implementation considerations that can guide decisions on whether, and how, to adopt self-testing in different contexts, including the populations being prioritized; the disease prevalence in that population; and the impact on accessibility of testing, health care services and result reporting.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Apresentação  do  PLANO  NACIONAL  DE  EXPANSÃO  DA  TESTAGEM  PARA  COVID-19  e orientações acerca dos dois
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                February 2021.
Improving our response to the ongoing COVID-19 pandemic in Africa requires regularly updated information, constant innovation, and considerable support towards research and development (R&D) for priorities that respond to the African realities. Shaping the research agenda and stimula...ting the generation, translation, and dissemination of valuable knowledge is one of the core functions of the African Academy of Sciences (AAS), African Centre for Disease Control (Africa CDC), and WHO-AFRO. We need answers to a list of critical research questions that respond to the current realities on the African continent to guide the COVID-19 outbreak control efforts
                                                                    more